Found 22 matching trials
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Learn More & Join Trial
Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer? N/A The recurrent pancreatic cancer (Rec-PC) after radical surgery is sometimes...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) PHASE2 This is a Phase II , Open-label , Investigator-initiated Trail of Sequentia...
Show More Location
Multiple Locations
Learn More & Join Trial
Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer PHASE2 This study is a prospective, open-label, randomized controlled trial that e...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP PHASE2 The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually ...
Show More Location
Takehiro Okabayashi
Learn More & Join Trial
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer PHASE1 This study is designed to explore the efficacy and safety of surufatinib co...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients PHASE2 Pancreatic cancer is one of the deadliest tumor types, there is no effectiv...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas PHASE2 A randomized multi-center phase II trial of nab-paclitaxel in combination w...
Show More Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Location
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract PHASE2 Gemcitabine plus cisplatin have been the most studied and used anticancer a...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial